Browsing by Author "Salinas Velastegui, Verónica Gabriela"

Now showing 1 - 5 of 5

Disfunción eréctil como indicador de enfermedad cardiovascular
(Universidad Técnica de Ambato/ Facultad de Ciencias de Salud /Carrera de Medicina, 2023-06-09) Rivas Manzano, María Cristina; Salinas Velastegui, Verónica Gabriela
Introduction: Sexual dysfunction in male patients is considered as the difficulty to maintain or achieve a firm penile erection, therefore, a difficulty to maintain satisfactory sexual relations. Worldwide, it is estimated that 150 million male patients suffer from this disease and the average age is between 40 and 70 years of life. It is worth mentioning that cardiovascular disease is associated with this pathology thanks to fulfilling similar pathophysiological mechanisms. Objective: To analyze the current bibliography and the relationship between erectile dysfunction as an indicator of cardiovascular disease. Materials and methods: Information was collected from scientific articles in different search engines and databases such as PubMed and Medline, variants of the keyword headings, and combinations of words for erectile dysfunction and indicators of cardiovascular disease were used, articles were collected from 2017 until 2022, without language limitation, about erectile dysfunction as an indicator of cardiovascular disease. Among the inclusion criteria we have articles focused on erectile dysfunction as an indicator of cardiovascular disease and articles with original data (cohort case series, retrospective, clinical case-control studies). Studies related only to cardiovascular disease and articles with little explanation of the relationship between erectile dysfunction and cardiovascular damage were excluded from the review studies. Results: It was evidenced that the most frequent cardiovascular pathologies that coexist in patients with ED (erectile dysfunction) are: 62% acute myocardial infarction, 44% associated with cardiovascular events, 39% cerebrovascular accidents and increased mortality in 25%. %. The onset time of cardiovascular disease after presenting erectile dysfunction in men is around 3 to 5 years (with an average of 4 years), which favors a crucial period for the identification of this pathology and the prevention of diseases with high mortality. Conclusions: There is good evidence regarding erectile dysfunction as an indicator of cardiovascular disease, which is why erectile dysfunction is considered an independent factor in predicting a cardiovascular event after the clinical presentation and vice versa, associating it as a clinical entity with great value at present, favoring immediate prevention after said finding, so it is important to raise awareness of the value of going to the consultation early.
DOLOR CRÓNICO Y SU ABORDAJE CON CANNABIDIOL: UNA OPCIÓN TERAPÉUTICA
(Universidad Técnica de Ambato/ Facultad de Ciencias de Salud /Carrera de Medicina, 2024-09-25) Vega Cueva, John Omar; Salinas Velastegui, Verónica Gabriela
Introduction: chronic pain is a health problem that affects millions of people in the world, generating an important biopsychosocial problem, which is why there are several types of therapeutic approaches, such as the use of cannabidiol for its anti-inflammatory, analgesic and neuroprotective qualities. Objectives: perform a bibliographic review on cannabidiol and how this active ingredient is a treatment option for chronic pain.Materials and methods: a search on cannabidiol as a treatment for chronic pain was carried out in several databases such as: Medline/PubMed, LILACS-BIREME and SciELO, including inclusion and exclusion criteria of the reviewed articles.Results: chronic pain is a condition that is characterized by the persistence of pain for more than 3 months, affecting quality of life and whether or not it is associated with true tissue damage. Worldwide, it affects more than 2 billion people and in Ecuador, about 21% of the population suffers from this pathology. Chronic pain can be of various types such as: neuropathic pain, nociceptive pain, centralized pain, mixed pain and idiopathic pain, which have unique characteristics that allow their differentiation.Cannabidiol has been involved in severalinvestigations to treat chronic pain. This is a chemical compound found in the cannabis plant, along with another variety of so-called cannabinoids, such as tetrahydrocannabidiol (THC), which is characterized by its effects. psychoactive, while cannabidiol lacks them. Generally speaking, cannabidiol acts on the body's endocannabinoid system, which regulates pain, immune function, etc. For this reason, it is believed that cannabidiol can reduce pain and inflammation. Although there is no minimum or maximum dose of cannabidiol to treat chronic pain, it can vary from 10 mg to 6000 mg. Therefore, strengthening research regarding cannabidiol as a therapy for chronic pain is vital to determine if it can be an alternative to the classic treatments that exist for chronic pain.Conclusions: several investigations have been carried out regarding the use of cannabidiol independently as a therapy for the treatment of pain, where no clear results have been found regarding the effectiveness of this medication, in additionto the fact that the result found will depend on the dosage. given to the population that has undergone this treatment scheme.
EFECTOS DEL USO DE LA TOXINA BOTULÍNICA TIPO A EN LA HIPERHIDROSIS: UNA REVISIÓN BIBLIOGRÁFICA
(Universidad Técnica de Ambato/ Facultad de Ciencias de Salud /Carrera de Medicina, 2024-09-25) Meneses Guaman, Kevin Alexander; Salinas Velastegui, Verónica Gabriela
The hyperhidrosis is a condition that causes excessive sweating unrelated to physical activity or body temperature, affecting the quality of life, generating physical discomfort and social isolation for those who suffer from it. It is classified as primary focal, located in: armpits, hands, feet and face, with no apparent cause although attributed to hyperactivity of the sweat glands, and secondary, caused by underlying diseases. Therapeutic management depends on its severity and includes antiperspirants, medications, non-invasive techniques such as iontophoresis, especially botulinum toxin type A (TB-A), effective for severe cases or those resistant to other treatments and which is the subject of this review, and surgery. last option for extreme cases. As for TB-A, it is a neurotoxin that blocks the release of acetylcholine, a neurotransmitter that stimulates sweat glands, so it is applied through injections in the affected area. Visible effects occur between 2 and 4 days, with an average duration of the effect of 4 to 8 months. Adverse reactions are generally mild, it is contraindicated in pregnancy, lactation, allergy to TB-A and neuromuscular diseases. The main objective is to analyze the most recent aspects in the use of botulinum toxin type A (TB-A) in the treatment of hyperhidrosis. Materials: systematic bibliographic review of documents from societies, journals and scientific studies in the field of dermatology, related to non-surgical therapy of hyperhidrosis and oriented to the use of botulinum toxin type A (TB-A). Regarding the results, we can indicate that the application of TB-A is considered a safe treatment for hyperhidrosis. Conclusion: the use of botulinum toxin type A is a good treatment for hyperhidrosis, however its treatment is temporary.
“Embarazo ectópico cornual”
(Universidad Técnica de Ambato - Facultad de Ciencias de la Salud - Carrera de Medicina, 2018-10-01) Salinas Velastegui, Verónica Gabriela; Belalcázar Sánchez Dra. Esp., Yajaira Monserrath
Ectopic pregnancy is considered one of the main causes of maternal mortality, and one of the most frequent problems in Obstetrics services, both public and private, is for this reason that it is decided to present this case of rare incidence worldwide, with in order to know the causes, diagnosis, risk factors and proper management of this pathology. The case analysis to be presented corresponds to a 34 year old female patient, resident in Ambato, higher education, mestizo, without significant personal pathological history, with gynecological and obstetric history: date of last menstruation April 3, 2017, gestational age 9.2 weeks of gestation, gestations: 2, deliveries: 0, abortions: 1, live children: 0, dead children: 0, pregnancy 1: spontaneous abortion at 5 weeks of gestation, pregnancy 2: current. Patient who enters the gynecological emergency service of the Ambato General Hospital (IESS) due to scarce vaginal bleeding of chocolate color of 15 days of evolution, at the physical examination: normal vital signs, abdomen: slightly distended, depressible not painful on palpation, region inguinogenital; presence of little chocolate secretion, tests are requested which report: positive BHCG in blood, progesterone 8.18 ng/ml, EMO: infectious, transvaginal ultrasound: complex left adnexal mass, empty uterine cavity, reason for which laparoscopy is performed exploratory study in which there is a non-injured left cornual ectopic pregnancy, subserous uterine myoma and conversion to laparotomy is decided for ectopic pregnancy removal and incidental myomectomy; postsurgical with satisfactory evolution, high in good conditions.
FACTORES DE RIESGO INTRÍNSECOS Y EXTRÍNSECOS QUE FAVORECEN EL DESARROLLO DE FIBROSIS PULMONAR EN PACIENTES MAYORES DE 65 AÑOS, REVISIÓN DE LA LITERATURA
(Universidad Técnica de Ambato/ Facultad de Ciencias de Salud /Carrera de Medicina, 2024-06-10) Tulmo Quimbita, Joseline Estefanía; Salinas Velastegui, Verónica Gabriela
Pulmonary fibrosis is a pathological entity characterized by damage to the lung parenchyma, causing abnormal tissue scarring. This pathology originates from respiratory infections and chronic obstructive pulmonary disease (COPD), a common pathology in patients over 40 years of age. age, is currently the third cause of death worldwide. Risk factors can be extrinsic such as: ingestion of biomass smoke, tobacco, occupational pollutants, among others, intrinsic factors depend directly on the patient such as: genetic factors, weight and gestational age at birth, history of recurrent respiratory infections in childhood , the symptoms usually range from mild to severe, this will depend on the degree of lung injury present, the treatment and measures to be considered for the improvement of the individual will depend on the damage and the current symptoms. Objectives: To carry out a bibliographic review on the intrinsic and extrinsic risk factors that favor the development of pulmonary fibrosis in patients over 65 years of age through a bibliographic search. Material and methods: search for information on the risk factors that favor the development of pulmonary fibrosis in patients >65 years of age in the following databases: Medline/PubMed, LILACS-BIREME and SciELO, including AND and OR operators. Results: the main triggering factor for the appearance of pulmonary fibrosis will be the presence of COPD, a multifactorial pathology. Conclusions: pulmonary fibrosis is a pathology that entails significant complications in patients; it can present with mild symptoms where the ventilatory process is still sustained to conditions where ventilation is totally ineffective.